Provided by Tiger Fintech (Singapore) Pte. Ltd.

Plus Therapeutics, Inc.

1.57
+0.13009.03%
Pre-market: 1.34-0.2300-14.65%04:47 EDT
Volume:103.78M
Turnover:198.81M
Market Cap:9.26M
PE:-0.51
High:2.31
Open:2.02
Low:1.27
Close:1.44
Loading ...

PSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer Therapy

Zacks
·
07 Mar

Plus Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
07 Mar

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
07 Mar

Plus Therapeutics' Brain Cancer Therapy Shows Promise in Early-Stage Study; Shares Rise

MT Newswires Live
·
07 Mar

Plus Therapeutics announces publication of results on 186Re Obisbemeda

TIPRANKS
·
07 Mar

Equity Markets Drop as US Layoffs Surge, Tariff Tumult Persists

MT Newswires Live
·
07 Mar

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live
·
07 Mar

Equity Markets Fall as US Layoffs Surge in February

MT Newswires Live
·
07 Mar

Top Midday Gainers

MT Newswires Live
·
07 Mar

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live
·
07 Mar

Plus Therapeutics Gets FDA Orphan Drug Designation for Rhenium Obisbemeda in Lung Cancer; Shares Surge

MT Newswires Live
·
06 Mar

BRIEF-Plus Therapeutics Granted U.S. FDA Orphan Drug Designation For Rhenium (186Re) Obisbemeda

Reuters
·
06 Mar

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients With Lung Cancer

THOMSON REUTERS
·
06 Mar

Plus Therapeutics Announces New Employment Inducement Grants

GlobeNewswire
·
06 Mar

Plus Therapeutics Expects $15 Million in Gross Proceeds From Private Placement of Units; Shares Fall

MT Newswires Live
·
05 Mar

Plus Therapeutics sees $15M in gross proceeds from private placement

TIPRANKS
·
05 Mar